<?xml version='1.0' encoding='utf-8'?>
<document id="17441219"><sentence text="Simultaneous determination of midazolam and 1'-hydroxymidazolam in human plasma by liquid chromatography with tandem mass spectrometry."><entity charOffset="30-39" id="DDI-PubMed.17441219.s1.e0" text="midazolam" /><entity charOffset="44-63" id="DDI-PubMed.17441219.s1.e1" text="1'-hydroxymidazolam" /><pair ddi="false" e1="DDI-PubMed.17441219.s1.e0" e2="DDI-PubMed.17441219.s1.e0" /><pair ddi="false" e1="DDI-PubMed.17441219.s1.e0" e2="DDI-PubMed.17441219.s1.e1" /></sentence><sentence text="A sensitive and simple liquid chromatography-tandem mass spectrometry method for the determination of midazolam and 1'-hydroxymidazolam in human plasma has been developed and validated with a dynamic range of 0"><entity charOffset="102-111" id="DDI-PubMed.17441219.s2.e0" text="midazolam" /><entity charOffset="116-135" id="DDI-PubMed.17441219.s2.e1" text="1'-hydroxymidazolam" /><pair ddi="false" e1="DDI-PubMed.17441219.s2.e0" e2="DDI-PubMed.17441219.s2.e0" /><pair ddi="false" e1="DDI-PubMed.17441219.s2.e0" e2="DDI-PubMed.17441219.s2.e1" /></sentence><sentence text="1-250 ng/mL" /><sentence text=" The analysis was based on semi-automated liquid-liquid extraction followed by evaporation of the extraction solvent, reconstitution and chromatography on a reversed-phase C(18) column" /><sentence text=" The mobile phase consists of 5 mm ammonium acetate and methanol and runs in gradient at a flow rate of 0"><entity charOffset="30-51" id="DDI-PubMed.17441219.s5.e0" text="5 mm ammonium acetate" /><entity charOffset="56-64" id="DDI-PubMed.17441219.s5.e1" text="methanol" /><pair ddi="false" e1="DDI-PubMed.17441219.s5.e0" e2="DDI-PubMed.17441219.s5.e0" /><pair ddi="false" e1="DDI-PubMed.17441219.s5.e0" e2="DDI-PubMed.17441219.s5.e1" /></sentence><sentence text="25 mL/min with column temperature of approximately 20 degrees C" /><sentence text=" The entire column effluent was transferred into the LC-MS/MS interface operated in positive electrospray ionization mode" /><sentence text=" The chromatographic run time was 4" /><sentence text="3 min per injection, with retention times for midazolam, 1'-hydroxymidazolaml and the internal standard, triazolam, of 2"><entity charOffset="46-55" id="DDI-PubMed.17441219.s9.e0" text="midazolam" /><entity charOffset="57-77" id="DDI-PubMed.17441219.s9.e1" text="1'-hydroxymidazolaml" /><entity charOffset="105-114" id="DDI-PubMed.17441219.s9.e2" text="triazolam" /><pair ddi="false" e1="DDI-PubMed.17441219.s9.e0" e2="DDI-PubMed.17441219.s9.e0" /><pair ddi="false" e1="DDI-PubMed.17441219.s9.e0" e2="DDI-PubMed.17441219.s9.e1" /><pair ddi="false" e1="DDI-PubMed.17441219.s9.e0" e2="DDI-PubMed.17441219.s9.e2" /><pair ddi="false" e1="DDI-PubMed.17441219.s9.e1" e2="DDI-PubMed.17441219.s9.e1" /><pair ddi="false" e1="DDI-PubMed.17441219.s9.e1" e2="DDI-PubMed.17441219.s9.e2" /></sentence><sentence text="5, 2" /><sentence text="3 and 2" /><sentence text="1 min, respectively" /><sentence text=" The intra-day and inter-day precision (RSD %) and accuracy (bias %) of the quality control samples were &lt;15" /><sentence text="0% and within +/-13%, respectively" /><sentence text=" The current method has been applied to a clinical drug-drug interaction study in human" /><sentence text="" /></document>